Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
17,977,495
-
Share change
-
-747,081
-
Total reported value
-
$6,631,337,034
-
Put/Call ratio
-
280%
-
Price per share
-
$368.97
-
Number of holders
-
417
-
Value change
-
-$257,488,346
-
Number of buys
-
194
-
Number of sells
-
185
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2015
As of 30 Jun 2015,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
417 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,977,495 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, UBS Group AG, MANAGED ACCOUNT ADVISORS LLC, CHURCHILL MANAGEMENT Corp, and SG Americas Securities, LLC.
This page lists
417
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.